H.R.2503 - AIM Act of 2017115th Congress (2017-2018) |
|Sponsor:||Rep. Paulsen, Erik [R-MN-3] (Introduced 05/17/2017)|
|Committees:||House - Ways and Means; Energy and Commerce|
|Latest Action:||House - 05/30/2017 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.2503 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (05/17/2017)
Accelerating Innovation in Medicine Act of 2017 or the AIM Act of 2017
This bill requires the Centers for Medicare & Medicaid Services (CMS) to develop, maintain, and make publicly available a list of medical devices that shall be voluntarily excluded from payment under the Medicare program. A Medicare beneficiary who consents to receive such a medical device shall be responsible for payment for the device.
A manufacturer seeking to have a medical device included in the list must submit a request for inclusion to the CMS, in accordance with specified timelines. As a condition for a device's continued inclusion on the list, a manufacturer must provide the CMS with data on clinical studies completed with respect to the device.